Labcyte Receives Patent for Producing Mono-Dispersed and Multi-Layer Particles with Focused Acoustics
Dr. Elaine J. Heron, Chief Executive Officer of Labcyte Inc., said, "Small particles of controllable size and composition provide predictability in a variety of applications. Uniformity in particle size allows materials to behave and function consistently, an attribute that is especially advantageous for the pharmaceutical industry, where the particle size of a therapeutic agent can affect the dissolution rate, bioavailability, and delivery to targeted portions of the lung."
Most read news
Organizations
Other news from the department research and development
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.